Surfactant effects on the physical characteristics of Amphotericin B-containing nanostructured lipid carriers

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 372, Issue 1-3, 2010, Pages 73-79

  Tan, S W ^a   Billa, N ^a   Roberts, C R ^b   Burley, J C ^b  

^a UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Amphotericin B; Lipid; Nanostructured; Surfactant

Indexed keywords

LEACHING; LIQUIDS; OLEIC ACID; PHOSPHOLIPIDS; POLYDISPERSITY; SODIUM; WAXES; ZETA POTENTIAL;

AMPHOTERICIN B; CUT-OFF; DRUG LOADING; ELECTROSTATIC REPULSION; IONIC SURFACTANTS; MODERATE CONCENTRATION; NANO-STRUCTURED; NANOSTRUCTURED LIPID CARRIERS; NONIONIC; PHYSICAL CHARACTERISTICS; PLURONIC F-127; PROCESSING VARIABLES; SODIUM CHOLATE; SULPHATES; SURFACTANT; SURFACTANT EFFECTS; TWEEN 80; ULTRA-SONICATION;

SURFACE ACTIVE AGENTS;

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CHOLIC ACID; DODECYL SULFATE SODIUM; IONIC SURFACTANT; LIPID; NANOMATERIAL; OLEIC ACID; PHOSPHATIDYLCHOLINE; POLOXAMER; POLYSORBATE 80; PROPOLIS; SOLID LIPID NANOPARTICLE; SURFACTANT; THEOBROMA OIL;

ARTICLE; CRYSTAL STRUCTURE; DISPERSION; ENTROPY; LEACHING; PARTICLE SIZE; PRIORITY JOURNAL; STEREOSPECIFICITY; ZETA POTENTIAL;

EID: 78649445308     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2010.09.030     Document Type: Article

References (27)

1. De Marie S., Janknegt R., Bakker-Woudenberg I.A.J.M. Clinical use of liposomal and lipid-complexed Amphotericin B. J. Antimicrob. Chemother. 1994, 33:907-916.
2. Müller R.H. Colloidal Carriers for Controlled Drug Delivery and Targeting: Modification, Characterization and In vivo Distribution 1991, Wissenschaftliche Verlagsgesellschaft, CRC Press, Boca Raton.
3. Ching M.S., Raymond K., Bury R.W., Mashford M.L., Morgan D.J. Absorption of orally administered amphotericin B lozenges. Br. J. Clin. Pharm. 1983, 16:106-108.
4. Risovic V., Sachs-Barrable K., Boyd M., Wasan K.M. Potential mechanisms by which Peceol increases the gastrointestinal absorption of amphotericin B. Drug Dev. Ind. Pharm. 2004, 30:767-774.
5. Dupont B. Overview of the lipid formulations of amphotericin B. J. Antimicrob. Chemother. 2002, 49:31-36.
6. Hussain N., Jaitley V., Florence A.T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Deliv. Rev. 2001, 50:107-142.
7. Muller R.H., Runge S.A. Solid lipid nanoparticles (SLN) for controlled drug delivery. Submicron Emulsions in Drug Targeting and Delivery 2010, 219-234. Harwood Academic Publishers, Amsterdam. S. Benita (Ed.).
8. Mehnert W., Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001, 47:165-196.
9. Lipospheres in Drug Targets and Delivery: Approaches, Methods and Applications 2005, CRC Press, Florida. C. Nastruzzi (Ed.).
10. Kuo Y.C., Chen H.H. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 2009, 365:206-213.
11. Müller R.H., Radtke M., Wissing S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 2002, 242:121-128.
12. Jenning V., Thünemann A.F., Gohla S. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 2000, 199:167-177.
13. Han F., Li S.M., Yin R., Liu H.Z., Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloids Surf. A 2008, 315:210-216.
14. Fryer P., Pinschower K. The materials science of chocolate. MRS Bull. 2000, 12:25-29.
15. Attama A.A., Schicke B.C., Müller-Goymann C.C. Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems. Eur. J. Pharm. Biopharm. 2006, 64:294-306.
16. Bunjes H., Koch M.H.J., Westesen K. Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J. Pharm. Sci. 2003, 92:1509-1520.
17. Quintanar-Guerrero D., Fessi H., Allémann E., Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int. J. Pharm. 1996, 143:133-141.
18. York P., Grant D.J.W. A disruption index for quantifying the solid state disorder induced by additives or impurities. I. Definition and evaluation of heat of fusion. Int. J. Pharm. 1985, 25:57-72.
19. Duro R., Gomez-Amoza J.L., Martinez-Pacheco R., Souto C., Concheiro A. Absorption of polysorbate 80 on pyrantel pamoate: effects on suspension stability. Int. J. Pharm. 1998, 165:211-216.
20. ® block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release 2002, 82:189-212.
21. Levy M.Y., Schutze W., Fuhrer C., Benita S. Relationship between crystallization behavior and structure in Cocoa butter. J. Microencapsul. 1994, 11:79-92.
22. Helgason T., Awad T.S., Kristbergsson K., McClements D.J., Weiss J. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J. Colloids Interface Sci. 2009, 334:75-81.
23. Bechthold N., Tiarks F., Willert M., Landfester K., Antonietti M. Miniemulsion polymerization: applications and new materials. Macromol. Symp. 2000, 151:555-594.
24. O'Brien R. Fats and Oils Formulating and Processing for Applications 1998, Technomic Pub. Co., Lancaster, PA.
25. Marangoni A.G., Mcgauley S.E. Relationship between crystallization behavior and structure in Cocoa butter. Cryst. Growth Des. 2003, 3:95-108.
26. Schubert M.A., Schicke B.C., Muller-Goymann C.C. Thermal analysis of the crystallization and melting behavoir of lipid matrices and lipid nanoparticles containing high amounts of lecithin. Int. J. Pharm. 2005, 298:242-254.
27. Westesen K., Bunjes H., Koch M.H.J. Physicochemical characterisation of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release 1997, 48:223-236.